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Objectives: Vaginitis still remains as a health issue in women. It is notable that
Candida albicans producing biofilm is considered a microorganism responsible for
vaginitis with hard to treat. Also, Peganum harmala was applied as an anti fungal
in treatment for many infections in Iran. Therefore, this study goal to investigate
the role of P. harmala in inhibition of biofilm formation in C. albicans.
Methods: So, 27 C. albicans collected from women with Vaginitis, then subjected
for biofilm formation assay. P. harmala was applied as antibiofilm formation in C.
albicans.
Results: Our results demonstrated that P. harmala in concentration of 12 mg/ml
easily inhibited strong biofilm formation; while the concentrations of 10 and
6 mg/ml inhibited biofilm formation in moderate and weak biofilm formation C.
albicans strains, respectively.
Conclusion: Hence, the current study presented P. harmala as antibiofilm herbal
medicine for C. albicans; but in vivo study suggested to be performed to confirm
its effectiveness.1. Introduction
Unfortunately, vaginitis remains a health issue in
women. It has been estimated that there are around 10
million physician visits for vaginitis annually [1].
However, biofilm formation is known as a majorGhafourian), pakzadi2006@
ase Control and Prevention.
reativecommons.org/licensworldwide concern [2]. Despite this, there are a vast
majority of microbiology studies focusing on bacterial
biofilm, but there is less consideration to medically
important fungal biofilms. Among fungi, the genus
Candida, especially Candida albicans, is responsible for
around 15e20% of vaginitis cases in women [3].gmail.com (I. Pakzad).
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es/by-nc-nd/4.0/).
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formation by C. albicans occurred in the oral cavities,
environment, and vaginas of patients [4].
New drug discovery could also be useful for the
eradication of potent fungi in biofilm formation.
Herbal medicines are defined as natural products,
which are used in traditional medicine. The use of
medicinal plants goes back 60,000 years ago [5].
Peganum harmala, usually called Esfand, is a plant of
the family of Nitrariaceae. It is applied as a traditional
medicine for so many infections in Iran [6]. Hence, the
current study aimed to investigate the role of P. har-
mala in the inhibition of biofilm formation produced
by C. albicans.0%
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Figure 1. Biofilm formation among Candida albicans
collected from patients with vaginitis.2. Materials and methods
2.1. Organisms and identification
C. albicans were collected from vulvovaginal can-
didacies women in the Ilam province in the west of Iran.
The isolates were cultured on Sabouraud dextrose agar
and then re-identified with a germ tube test [7].
2.2. Cell culture
The P. harmala extract was tested for its cytotoxicity
effect on a Vero cell line. The percentage viability of the
cell line was carried out by using the MTT assay
(Sigma, United States).
2.3. Toxicity assay
The cells were coated in a 96-well flat bottom plates
at a density of 5,000e10,000 cells per well. Following
this, the cells were treated with different concentrations
of P. harmala ethanolic extract (1e100 mg/mL). After
24 hours, the MTT assay was applied to determine the
toxicity concentration of P. harmala. The absorbance of
the converted dye was measured at a wavelength of
570 nm with a background subtraction at 600 nm.
2.4. Biofilm formation assay
A 0.5 McFarland solution of C. albicans inoculated
to 200 uL lurian broth (LB broth) in 96 micro plates for
evaluation of biofilm formation. One colony from each
C. albicans was applied to inoculate 5 mL LB broth.
Then, the culture incubated for 24 hours at 35C with
aeration at 4 g. Then, 0.5 McFarland from each C.
albicans was prepared. Following this, 200 mL of each
C. albicans was transferred to a 96-well micro plate. The
experiment was performed in duplicate. LB broth
without C. albicans was considered as a negative con-
trol. The plates were incubated for 48 hours at 35oC.
2.5. Semiquantification of biofilm biomass
Biofilm biomass was quantified using a methodology
described by Mowat et al [8].2.6. Analysis of biofilm formation
The capacity of each strain to form a biofilm was
compared with that of the confluent biofilm-forming C.
albicans control by analyzing the absorbance of the
crystal violet stain obtained for each biofilm. This
allowed each isolate to be assigned a percentage value
depending on the proportion of biofilm biomass it was
able to establish after 48 hours in comparison with the
control (taken as 100%).
Isolates were also divided into three groups depend-
ing on whether they formed fully established biofilms
with 75% of the biomass of the positive control,
moderately adherent biofilms with 25e75% biomass, or
weak biofilms with 25% of the biomass of the positive
control.
2.7. Antibiofilm formation activity
determination of P. harmala
Different concentrations (1e15 mg/mL) of P. har-
mala were applied on the positive biofilm formation
strains. Then, the biofilm formation assay, as described
above, was performed to evaluate the efficacy of P.
harmala on biofilm formation by C. albicans isolates.
3. Results
3.1. Biofilm formation in C. albicans
Our results demonstrated that among 100 yeasts
responsible for vaginitis, 27% (nZ 27) of them were C.
albicans. Our analysis demonstrated that all types of
biofilm formation were observed; while the most biofilm
formation was observed as weak biofilms (37%,
nZ 10). The lowest biofilm formation was observed for
both moderate and strong biofilm formation (each, 7.4%,
nZ 2). The remaining strains (48.2%, nZ 13) showed
no biofilm formation (Figure 1).
3.2. P. harmala as a candidate for inhibition of
biofilm formation in C. albicans
The IC50 for P. harmala was 15 mg/mL. P. harmala,
in a concentration of 12 mg/mL, easily inhibited biofilm
formation on strong biofilm formation strains; while
118 E. Aboualigalehdari, et alconcentrations of 6 mg/mL and 10 mg/mL inhibited
biofilm formation in weak and moderate biofilm for-
mation C. albicans strains, respectively.
4. Discussion
C. albicans is considered as a human pathogen and
causes many infections ranging from severe to mild
candidacies. Many factors are involved in the pathoge-
nicity of C. albicans, including the production of
extracellular enzymes, biofilm formation, and surface
adherence [9,10]. Also, C. albicans is settled in the
vaginal cavity as a microbiota that causes vulvovaginal
candidiasis. Our finding demonstrated that there is
variation in biofilm formation in C. albicans, which is
consistent with obtained results by Sherry et al [11]. It
seems to be necessary to investigate traditional herbs
against pathogenic microorganisms. Our findings
demonstrated the antibiofilm effectiveness of P. har-
mala against C. albicans. However, more investigations,
including in vivo studies, are needed to study P. harmala
as an antibiofilm in C. albicans.
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